Edwards Lifesciences Stock News

Harding Loevner, an investment management firm, published its “Global Equity Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.

Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock?

Riding The Stock Waves: Update On The Medical Devices Sector

Related Stocks: EW , AMZN , EFX , VNT , HON , TSLA , KD ,

Benjamin Graham, the father of value investing, recommended investors look for stocks that have a current ratio higher than 2 and more working capital than long-term debt.

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

Following a decline of more than 15% in January, Edwards Lifesciences (EW) has bounced back after UBS upgraded the cardiac equipment company to Buy from Neutral, citing its potential in

"Mad Money" host Jim Cramer explained Tuesday why he expects to see a bounce back in shares of Edwards Lifesciences, Intuitive Surgical and Stryker.

"I think there are some true steals are developing in the medical device space because of omicron," the "Mad Money" host said.

Las Vegas, USA, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Vascular Access Devices Market is Expected to Surge at a Significant CAGR of 6.64% and is also Contemplated to Reach Upto USD 6.13 Billion by 2026, Estimates DelveInsight The Vascular Access Device market is anticipated to grow tremendously in the coming years due to many factors which include the rising prevalence of end-stage renal diseases and the rising number of vascular access surgeries, these are striving the Vascular Access Devices demand, thus driving the growth of Vascular Access Device market. DelveInsight''s Vascular Access Devices Market Insights and Forecast report provides the current and forecast Vascular Access Devices, upcoming innovation in the devices, individual market shares of the devices, challenges, drivers and barriers, market trends, and key competitors in the Vascular Access Devices. Some of the essential takeaways from the Vascular Access Devices Market report: According to DelveInsight analysis, North America is expected to dominate the overall Vascular Access Devices Market during the forecast period.

Shares of Edwards Lifesciences are down 5% in after-hours trading as the medical device company Q4 2021 results missed on both the top and bottom line.

Edwards Lifesciences reported light fourth-quarter sales while 2022 guidance came in narrowly below views. EW stock toppled.

Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q4 2021 Results - Earnings Call Transcript

According to the Good Companies Screen, a Premium value screen nested under the All-in-One Screener, five good companies that have outperformed the Standard & Poor's 500 index benchmark over the past